MRNS

Marinus Pharmaceuticals, Inc

Delisted

MRNS was delisted on the 10th of February, 2025.

104 hedge funds and large institutions have $411M invested in Marinus Pharmaceuticals, Inc in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 30 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
104
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$12.3M
Puts
$1.53M
Net Calls
Net Calls Change

Top Buyers

1 +$21.1M
2 +$19.9M
3 +$10.9M
4
SCM
Suvretta Capital Management
New York
+$9.24M
5
Jennison Associates
Jennison Associates
New York
+$8.77M

Top Sellers

1 -$5.7M
2 -$4.24M
3 -$3.1M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.76M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.09M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$341K
52
$281K
53
$279K
54
$263K
55
$258K
56
$251K
57
$221K
58
$214K
59
$212K
60
$209K
61
$204K
62
$203K
63
$166K
64
$161K
65
$161K
66
$159K
67
$158K
68
$157K
69
$141K
70
$130K
71
$128K
72
$116K
73
$108K
74
$106K
75
$91.8K